Introduction

The Direxion Daily Healthcare Bull 3X Shares ETF (NYSEARCA:CURE) has marginally outperformed the SPDR S&P 500 ETF Trust (SPY) so far in 2024, delivering a ~26% total return against the ~22% gain for the S&P 500-tracking ETF:

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.